Co-expression of transforming growth factor-β1 and glial cell line-derived neurotrophic factor in vestibular schwannoma

Otology and Neurotology

Volumn 25, Issue 3, 2004, Pages 359-365

  Diensthuber, M ^a   Brandis, A ^a   Lenarz, T ^a   Stöver, Timo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Glial cell line derived neurotrophic factor; Immunohistochemistry; Transforming growth factor 1; Vestibular schwannoma

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN RET; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GROWTH RATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR VOLUME;

GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NERVE GROWTH FACTORS; NEUROMA, ACOUSTIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4043172881     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200405000-00026     Document Type: Article

References (35)

1. Tos M, Thomsen J. Epidemiology of acoustic neuromas. J Laryngol Otol 1984;98:685-92.
2. Samii M, Tatagiba M, Matthies C. Vestibular schwannomas: surgical approach. J Neurosurg 2001;94:144-6.
3. Samii M, Matthies C. Gamma surgery for vestibular schwannoma. J Neurosurg 2000;92:892-4.
4. Moffat DA, Irving RM. The molecular genetics of vestibular schwannoma. J Laryngol Otol 1995;109:381-4.
5. Ridley AJ, Davis JB, Stroobant P, et al. Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells. J Cell Biol 1989;109:3419-24.
6. Miyazono K, Olofsson A, Colosetti P, et al. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 1991;10:1091-101.
7. Ebner R, Chen RH, Shum L, et al. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science 1993;260:1344-8.
8. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-46.
9. Rufer M, Flanders K, Unsicker K. Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve. J Neurosci Res 1994;39:412-23.
10. Cardillo MR, Filipo R, Monini S, et al. Transforming growth factor-beta1 expression in human acoustic neuroma. Am J Otol 1999;20:65-8.
11. Bar KJ, Saldanha GJ, Kennedy AJ, et al. GDNF and its receptor component Ret in injured human nerves and dorsal root ganglia. Neuroreport 1998;9:43-7.
12. Lin LF, Doherty DH, Lile JD, et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993;260:1130-2.
13. Jing S, Wen D, Yu Y, et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996;85:1113-24.
14. Trupp M, Arenas E, Fainzilber M, et al. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 1996;381:785-9.
15. Krieglstein K, Henheik P, Farkas L, et al. Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons. J Neurosci 1998;18:9822-34.
16. Schober A, Hertel R, Arumae U, et al. Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo. J Neurosci 1999;19:2008-15.
17. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
18. Aguiar PH, Tatagiba M, Dankoweit-Timpe E, et al. Proliferative activity of acoustic neurilemomas without neurofibromatosis determined by monoclonal antibody MIB 1. Acta Neurochir 1995;134:35-9.
19. Flanders KC, Ludecke G, Engels S, et al. Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development 1991;113:183-91.
20. Eckenstein FP. Fibroblast growth factors in the nervous system. J Neurobiol 1994;25:1467-80.
21. Yagi M, Kanzaki S, Kawamoto K, et al. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000;1:315-25.
22. Stöver T, Gong TL, Cho Y, et al. Expression of the GDNF family members and their receptors in the mature rat cochlea. Brain Res Mol Brain Res 2000;76:25-35.
23. Stöver T, Nam Y, Gong TL, et al. Glial cell line-derived neurotrophic factor (GDNF) and its receptor complex are expressed in the auditory nerve of the mature rat cochlea. Hear Res 2001;155:143-51.
24. Unsicker K, Flanders KC, Cissel DS, et al. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 1991;44:613-25.
25. Weerda HG, Gamberger TI, Siegner A, et al. Effects of transforming growth factor-beta1 and basic fibroblast growth factor on proliferation of cell cultures derived from human vestibular nerve schwannoma. Acta Otolaryngol 1998;118:337-43.
26. Russell FD, Koishi K, Jiang Y, et al. Anterograde axonal transport of glial cell line-derived neurotrophic factor and its receptors in rat hypoglossal nerve. Neuroscience 2000;97:575-80.
27. van Weering DH, Bos JL. Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation. J Biol Chem 1997;272:249-54.
28. Stark B, Carlstedt T, Risling M. Distribution of TGF-beta, the TGF-beta type I receptor and the R-II receptor in peripheral nerves and mechanoreceptors; observations on changes after traumatic injury. Brain Res 2001;913:47-56.
29. Rotzer D, Roth M, Lutz M, et al. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. EMBO J 2001;20:480-90.
30. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
31. Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989;63:1607-11.
32. Light JP, Roland JT Jr, Fishman A, et al. Atypical and low-grade malignant vestibular schwannomas: clinical implications of proliferative activity. Otol Neurotol 2001;22:922-7.
33. Irving RM, Moffat DA, Hardy DG, et al. A molecular, clinical, and immunohistochemical study of vestibular schwannoma. Otolaryngol Head Neck Surg 1997;116:426-30.
34. Labit-Bouvier C, Crebassa B, Bouvier C, et al. Clinicopathologic growth factors in vestibular schwannomas: a morphologic and immunohistochemical study of 69 tumors. Acta Otolaryngol 2000;120:950-4.
35. Kawamoto Y, Uozumi T, Kiya K, et al. Clinicopathologic growth factors of acoustic neuromas. Surg Neurol 1995;43:546-52.